bis (diethyldithiocarbamato)antimony(iii) derivatives with oxygen- and sulfur-donor...
TRANSCRIPT
This article was downloaded by: [University of Haifa Library]On: 26 August 2013, At: 22:12Publisher: Taylor & FrancisInforma Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House,37-41 Mortimer Street, London W1T 3JH, UK
Phosphorus, Sulfur, and Silicon and the RelatedElementsPublication details, including instructions for authors and subscription information:http://www.tandfonline.com/loi/gpss20
BIS(DIETHYLDITHIOCARBAMATO)ANTIMONY(III)DERIVATIVES WITH OXYGEN AND SULFUR DONORLIGANDS: SYNTHESIS, ESI–MASS AND SPECTRALCHARACTERIZATIONH. P.S. Chauhan a , Jaswant Carpenter a , Sumit Bhatiya a & Abhilasha Bakshi aa School of Chemical Sciences, Devi Ahilya University, Takshashila Campus, Khandwa Road,Indore, 452001, IndiaAccepted author version posted online: 05 Apr 2013.
To cite this article: Phosphorus, Sulfur, and Silicon and the Related Elements (2013):BIS(DIETHYLDITHIOCARBAMATO)ANTIMONY(III) DERIVATIVES WITH OXYGEN AND SULFUR DONOR LIGANDS: SYNTHESIS,ESI–MASS AND SPECTRAL CHARACTERIZATION, Phosphorus, Sulfur, and Silicon and the Related Elements, DOI:10.1080/10426507.2013.777729
To link to this article: http://dx.doi.org/10.1080/10426507.2013.777729
Disclaimer: This is a version of an unedited manuscript that has been accepted for publication. As a serviceto authors and researchers we are providing this version of the accepted manuscript (AM). Copyediting,typesetting, and review of the resulting proof will be undertaken on this manuscript before final publication ofthe Version of Record (VoR). During production and pre-press, errors may be discovered which could affect thecontent, and all legal disclaimers that apply to the journal relate to this version also.
PLEASE SCROLL DOWN FOR ARTICLE
Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) containedin the publications on our platform. However, Taylor & Francis, our agents, and our licensors make norepresentations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of theContent. Any opinions and views expressed in this publication are the opinions and views of the authors, andare not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon andshould be independently verified with primary sources of information. Taylor and Francis shall not be liable forany losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoeveror howsoever caused arising directly or indirectly in connection with, in relation to or arising out of the use ofthe Content.
This article may be used for research, teaching, and private study purposes. Any substantial or systematicreproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in anyform to anyone is expressly forbidden. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 1
BIS(DIETHYLDITHIOCARBAMATO)ANTIMONY(III) DERIVATIVES WITH
OXYGEN AND SULFUR DONOR LIGANDS: SYNTHESIS, ESI–MASS AND
SPECTRAL CHARACTERIZATION
H.P.S. Chauhan*, Jaswant Carpenter§, Sumit Bhatiya
† and Abhilasha Bakshi
‡ School of Chemical Sciences, Devi Ahilya University, Takshashila Campus, Khandwa Road,
Indore–452001, India
*Corresponding author; E-mail: [email protected],
Tel.: 0731-2460208 (O), Mob.: +91-9826219748
Fax: 0731-2365782
§E-mail: [email protected],
†Email: [email protected],
‡ Email: [email protected]
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 2
Abstract
Replacement reactions of bis(diethyldithiocarbamato)antimony(III) chloride have been carried
out with oxygen and sulfur donor ligands such as disodium oxalate, sodium acetate, sodium
salicylate, benzoic acid, thioglycolic acid, acetylacetone, thiphenol, ethane-1,2-dithiol and 2,2-
dimethylpropane-1,3-diol to give mixed bis(diethyldithiocarbamato)antimony(III) derivatives of
the corresponding ligands. These derivatives have been characterized by the physicochemical
[melting point & molecular weight determination, elemental analysis (C, H, N, S and Sb)],
spectral [FT–IR, far IR, NMR (1H and
13C)], ESI–mass, powder XRD and SEM studies.
Abstract Graphical
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 3
Keywords
antimony(III); dithiocarbamates; 1H and 13C NMR; ESI-mass; powder XRD; SEM.
[Supplementary materials are available for this article. Go to the publisher’s online
edition of Phosphorus, Sulfer, and Silicon and the Related Elements for the following
free supplemental files: Additional figures and tables.]
<AQ> Editorial work on your manuscript has created a file of supplemental materials
that will be available on-line only.</AQ>
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 4
INTRODUCTION
Carboxylic and phenolic ligands are versatile in nature and exhibit various types of coordination
patterns with transition, as well as main group metals. Dithiocarbamate complexes of various
metals are used in analytical chemistry1, medicines2, as antioxidants3, polymer photo stabilizers4,
precursor for creating sulfide film semiconductor5 and exhibit anti–alkylation6 and anti–HIV
properties7. These ligands and their antimony derivatives have been investigated as antiwear
agents or multifunctional additives to lubricants8. The compounds of antimony containing Sb–S
bonds have been widely used in industrial processes9; Takahashi et al. have reported some
antimony compounds can affect the repair of a DNA double strand breaks10. Trivalent antimony
compound have also been used as drugs for the treatments of laishmaniasis span more than 50
years11, 12. It has been reported that compounds of organoantimony possess potent in vitro
activity against certain cancer cells13, and find extensive applications in chemotherapy14–16,
antimicrobial14, antiparasitic15, and antitumor16–18 activities. A large number of antimony
compounds have been tested as bactericides17, fungicides12, and antifertility agents19.
In view of the interesting results obtained earlier on some dithiolate As(III), Sb(III), and
Bi(III) derivatives with sulfur and oxygen donor ligands20–23 in our laboratory, we report herein
synthesis, spectroscopic characterization and ESI-mass studies of some mixed
bis(diethyldithiocarbamato)antimony(III) oxo and thio carboxylic and phenolic compounds of
the general formula [(C2H5)2NCS2]2SbL where L = ½ OOCCOO (1), OOCCH3 (2),
OOCC6H4(OH) (3), OOCC6H5 (4), SCH2COOH (5), SOCCH3 (6), CH3C(O)CHC(O)CH3 (7),
SC6H5 (8), ½ SCH2CH2S (9) and ½ OCH2C(CH3)2CH2O (10).
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 5
RESULTS AND DISCUSSION
Synthesis
Bis(diethyldithiocarbamato)antimony(III) derivatives have been synthesized by the reactions of
bis(diethyldithiocarbamato)antimony(III) chloride with oxygen and sulfur donor ligands in 1:1
and 2:1 molar ratios in refluxing anhydrous benzene* for ~5h.
Scheme 1
Scheme 2
*Benzene is a carcinogenic solvent! This was used as the most suitable solvent for the
reactions. Benzene was collected and all precautions were taken to prevent discharge/release of
benzene. In future we will not use benzene as a solvent and will use some other alternative safer
solvents.
IR and far–IR
The bands of medium to strong intensity 1600–1700 cm–1 and 1200–1350 cm–1 are attributed to
asymmetric υ(COO–) and symmetric υ(COO–) respectively20–24. The bands present due to υ(C–
N) at 1450–1476 cm–1 in the free ligands are shifted to higher frequencies in the complexes and
present in the region 1490–1510 cm–1 and another band at 1050–1070 cm–1 due to υ(C–S)
indicating anisobidentade behavior of the dithiocarbamate group in the complexes25–27. In
addition to these, the bands appearing between 500–600 cm–1 and 300–350 cm–1 may be
assigned to υ(Sb–O) and υ(Sb–S) respectively.
1H NMR
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 6
All the spectra of these complexes exhibit the expected pattern without any appreciable shift
from the reported data21–24. The spectra of the dithiocarbamate exhibit CH3 protons signal at δ
1.25–1.35 which split into a triplet and CH2 protons at δ 3.70–3.80 which splits into a quartet. A
singlet at δ 10.35 is observed for the complex containing phenyl –OH (compound 3). In addition
to these, complexes also show expected protons resonance due to corresponding carboxylic and
phenolic proton of ligand moieties.
13C
NMR
The 13C NMR spectra of diethyldithiocarbamate (dtc) moieties show signals in the range δ 12.0–
12.4 and δ 48.6–49.1 due to β–C and α–C, respectively. All these complexes also show a weak
signal at δ 195.7–196.7 due to NCS2 carbon resonance as well as compound 1-6 exhibit an
expected weak signal between δ 169.8–172.6 due to COO carbon.
ESI–mass spectral studies
ESI–mass spectral data of the two of the synthesized complexes were obtained over a
temperature range (100–300oC), as these complexes might undergo a thermolytic decomposition
at elevated temperature. It is common with such type of complexes that molecular ion peak is not
observed; these may be attributed to the pyrolytic decomposition of the complexes in the direct
inlet chamber at the high temperature of the experiment or due to the electron impact28, 29. The
base peak [{(C2H5)NCS2}Sb]+ in both complexes is found to be the most abundance exhibit
strong chelating properties of the dithiocarbamate group. These ions are probably formed by the
cleavage of one of the Sb–S bond of bridging 1,2–dithiolate ligand in the complex 9. It is
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 7
supported by the [{(C2H5)2NCS2}Sb–S–CH2–CH2–S]+ fragment obtain at m/z 509 with 11%
abundance. ESI–mass spectral data of 9 and 10 are shown in Table S 1 and S 2.
Powder X–ray diffraction data
Powder X–ray diffraction pattern for four of the complexes 1, 4, 7 and 10 have been studied
which are showed in Figure 1, S 1, S 2 and S 3.
Figure 1
Complexes have monoclinic crystal lattice with unit cell volume V = 504.63 Å (1), V = 1252.05
Å (4), V = 604.88 Å (7), and V = 770.94 Å (10), and are crystalline in the nature. Average
particles size of the synthesized complexes were determined with the help of the Scherrer
formula26, In which particle size D is defined as 0.9λ /B cosθ, where 0.9 = constant, λ =
wavelength, B = angular width and θ = diffraction angle. The powder X–ray diffraction data of
all four complexes are shown in Table S 3, S 4, S 5 and S 6. In some deviation between the
distances (d) may exceed up to 1.65 as observed in Table S 5, which shows that synthesized
complexes are in multiphase complexes, as we synthesized mixed ligand complexes which
characteristic of both ligands as observed in X–ray diffraction pattern of complexes. Interplanar
d spacing and unit cell volume of the synthesized complexes were calculated by the formulae30:
V = abc sin β
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 8
We have obtained interplanar distances matched with complexes of
bis(diethyldithiocarbamato)antimony(III) with of oxalate, benzoate, acetylacetonate and 2,2-
dimethylpropane-1,3-diol ligands, which are equal and in some cases nearly matches to standard
diffraction card JCPDS 72–0022, 43–1978, 46–1954, 14–0882, 41–1634, and 38–1792.
Monoclinic crystal lattice shows that complexes have lower symmetry which is due to the
complex nature and lone pair of electron present on antimony which does not take part in
bonding and results in distorted geometry of complexes. Along with these formulae, other
informations related to our synthesized complexes are collected from the standard book30.
SEM studies
Scanning electron microscopic studies of four of the synthesized complexes, 1, 4, 7, and 10 have
been carried out at a magnification of ×500–50 µm and ×7500–2 µm. The particles of complex 1
(Figure S 4) and 7 (Figure S 5) possess highly irregular surface morphology and rough texture
appears with grooves and ridges on the surface which reveals that the complexes are crystalline
in nature.
Complex 4 (Figure S 6) and 10 (Figure S 7) have large aggregates or exist as
agglomerated particles. It is noteworthy that the agglomerates consist of a large number of tiny
particles. This implies that the agglomerates could result from the flocculation of primary
particles. The average particle size found from SEM shows that the complexes are nano range
(3.19 to 3.64 nm) crystalline solids.
Structure elucidation
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 9
In the IR spectra of all these synthesized complexes, the presence of strong band in the region
1490–1510 cm–1 due to υ(C–N) and another at 1050–1070 cm–1 due to υ(C–S) indicate the
anisobidentate nature of the dithiocarbamate ligands. In addition, the band appearing between
500–600 cm–1 and 300–350 cm–1 is due to of υ(Sb–O) and υ(Sb–S) for oxygen and sulfur donor
ligands respectively, which clearly indicates the bonding between antimony metal and oxygen
and sulfur atoms of the ligands.
Figure 2
Figure 3
On the basis of above studies tentative structures have been proposed as distorted
octahedral geometry with a stereochemically active lone pair of electron occupying one of the
vertex of the octahedra. Distorted octahedral geometry has also been supported by monoclinic
crystal system which also indicates lower symmetry of the complexes. Thus on the basis of
above studies and earlier reported data, it is tentatively concluded that complexes are crystalline
in nature, rough surface, exist as agglomerates, nano range particle size and having distorted
octahedral geometry with monoclinic crystal system.
EXPERIMENTAL
Material and methods
All the experimental manipulations have been carried out under moisture free condition.
Antimony trichloride (E.Merck) was distilled before use. Solvents (benzene, dichloromethane,
chloroform etc.) were purified by standard methods31. Anhydrous benzene was handled very
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 10
carefully as it is carcinogenic. Sodium diethyldithiocarbamate (BDH) and ligands [benzoic acid,
thiobenzoic acid, thioacetic acid, thiophenol, sodium salicylate, thioglycolic acid and disodium
oxalate (all Fluka and Merck Germany)] were used as received without further purification.
Antimony(III)tris(diethyldithiocarbamate) and bis(diethyldithiocarbamato)–antimony(III)
chloride were prepared by the method reported in the literature20, 21.
Synthesis of compound 2–8 in 1:1 molar ratios
Synthesis of [(C2H5)2NCS2]2SbOOCCH3
Bis(diethyldithiocarbamato)antimony(III)chloride (1.5g; 0.33 mmol) dissolved in benzene (~40
mL) was added to sodium acetate (0.27g; 0.33 mmol) drop by drop in a round bottom flask. The
reaction mixture was refluxed for ~5h. It was cooled and precipitated sodium chloride was
filtered off. The solvent was removed under reduced pressure to get the product. Finally the
compound was crystallized in dichloromethane.
All other compounds (3–8) were synthesized by adopting the similar procedure.
Synthesis of compound 1, 9 and 10 in 2:1 molar ratios
Synthesis of [{(C2H5)2NCS2}2Sb(µ2-OOCCOO)]
The benzene solution (~40 mL) of bis(diethyldithiocarbamato)antimony(III) chloride (1.49g;
3.30 mmol) was added drop by drop to disodium oxalate (0.22g; 1.64 mmol). The reaction
mixture was refluxed for ~5h and filtered. The solvent from the filtrate was removed under
vacuum to obtain the product. The compound 9 and 10 also prepared by similar procedure.
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 11
Analytical methods and physical measurements
Antimony was estimated iodometrically and sulfur was estimated gravimetrically as barium
sulphate32. Melting points were determined on a B10 Tech India melting point apparatus and are
uncorrected. Molecular weights were determined cryoscopically in benzene. 1H (at 500 MHz)
and 13C (at 125.8 MHz) NMR spectra were obtained on a Brucker FT NMR spectrometer in
CDCl3 solution using TMS as an internal standard, Infrared spectra (KBr) were recorded at BX
series in the range 4000–400 cm–1 and far–IR spectra were recorded as a Nujol mull over CsI
disks using a Megna–IR Spectrophotometer–550 instrument in the range 600–50 cm–1. Powder
X–ray diffraction studies performed on diffractometer system XPERT–PRO using CuK,
radiation at a wavelength of 1.54 and SEM studies were carried out on and JSM–5600
scanning electron microscope at accelerating voltage of 0.5–30 kV.
Analytical and spectral data
Analytical and spectral data (state, colour, yield, melting point, IR, NMR and elemental analysis)
of individual compound are as follows:
(1) White solid; yield: 90 %, m.p.: 98oC, M.W. found (calcd.): 913 (925) g/mol; 1H NMR: δ 1.27
(t, J = 7.0 Hz, 24H, CH3 dtc), 3.74 (q, J = 7.0 Hz, 16H, CH2 dtc). 13C NMR: δ 12.1 (CH3), 49.1
(CH2), 171.6 (COO), 195.7 (NCS2); IR (vmax cm–1): 2960, 1698, 1510, 1265, 1070, 570, 304;
Analysis (%): for C22H40N4O4S8Sb2, found: Sb 26.21, S 27.54, C 27.89, H 4.24, N 5.81, calcd.:
Sb 26.34, S 27.74, C 28.58, H 4.36, N 6.06.
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 12
(2) Light green sticky solid; yield: 72 %, M.W. found (calcd.): 468 (477) g/mol; 1H NMR: δ 1.24
(t, J = 7.0 Hz, 24H, CH3 dtc), 2.15 (s, 3H, CH3 acetate), 3.71 (q, J = 7.0 Hz, 16H, CH2 dtc). 13C
NMR: δ 12.2 (CH3 dtc), 22.7 (CH3 acetate), 48.7 (CH2 dtc), 170.1 (COO), 196.6 (NCS2); IR (vmax
cm–1): 2990, 1685, 1510, 1265, 1050, 570, 310; Analysis (%): for C12H23N2O2S4Sb, found: Sb
25.01, S 26.72, C 29.92, H 4.72, N 5.68, calcd.: Sb 25.51, S 26.87, C 30.19, H 4.86, N 5.87.
(3) Yellow semi–solid; yield: 79 %, M.W. found (calcd.): 541 (555) g/mol; 1H NMR: δ 1.25 (t, J
= 7.0 Hz, 24H, CH3 dtc), 3.71 (q, J = 7.0 Hz, 16H, CH2 dtc), 7.30 (m, 4H, C6H4), 10.35 (s, 1H
C2–OH). 13C NMR: δ 12.2 (CH3), 48.8 (CH2), 117.1 (Ring C–3), 118.7 (Ring C–4), 125.4 (Ring
C–6), 129.3, (Ring C–5), 129.8 (Ring C–1), 161.8 (Ring C–2), 172.6 (COO), 196.6 (NCS2). IR
(vmax cm–1): 2985, 1655, 1500, 1270, 1070, 560, 310; Analysis (%): for C17H25N2O3S4Sb, found:
Sb 21.75, S 22.89, C 36.32, H 4.42, N 4.89, calcd.: Sb 21.92, S 23.09, C 36.76, H 4.54, N 5.04.
(4) Light yellow solid; yield: 95 %, m.p.: 57oC, M.W. found (calcd.): 524 (539) g/mol; 1H
NMR: δ 1.23 (t, J = 7.0 Hz, 24H, CH3 dtc), 3.72 (q, J = 7.0 Hz, 16H, CH2 dtc), 7.39 (t, J = 7.5
Hz, 1H, Ring C–4), 7.52 (s, J = 7.5 Hz, 1H, Ring C–3), 8.02 (d, J = 7.0 Hz, 1H, ring C–2). 13C
NMR: 12.4 (CH3), 48.9 (CH2), 128.5 (Ring C–3, C–4), 129.8 (Ring C–2, C–6), 130.3 (Ring C–
1), 133.6 (Ring C–4), 171.8 (COO), 196.7 (NCS2); IR (vmax cm–1): 2995, 1670, 1504, 1290,
1076, 565, 315; Analysis (%): for C17H25N2O2S4Sb, found: Sb 22.50, S 23.66, C 37.72, H 4.55,
N 4.96, calcd.: Sb 22.57, S 23.78, C 37.85, H 4.67, N 5.19.
(5) Light yellow solid; yield: 88 %, m.p.: 96oC, M.W. found (calcd.): 497 (509) g/mol; 1H NMR:
δ 1.35 (t, J = 7.0 Hz, 24H, CH3 dtc), 2.97 (s, 2H, CH2 acetate), 3.73 (q, J = 7.5 Hz, 16H, CH2
dtc), 9.10 (s, 1H, COOH). 13C NMR: 12.2 (CH3 dtc), 42.5 (CH2 acetate), 48.6 (CH2 dtc), 181.7
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 13
(COO), 196.3 (NCS2); IR (vmax cm–1): 2970, 1640, 1510, 1265, 1050, 304; Analysis (%): for
C12H23N2O2S5Sb, found: Sb 23.74, S 31.40, C 27.88, H 4.36, N 5.33, calcd.: Sb 23.90, S 31.47,
C 28.29, H 4.55, N 5.50.
(6): Orange solid; yield: 92 %, m.p.: 79oC, M.W. found (calcd.): 481 (493) g/mol; 1H NMR: δ
1.24 (t, J = 7.5 Hz, 24H, CH3 dtc), 2.21 (s, 3H, CH3 acetate), 3.71 (q, J = 7.0 Hz, 16H, CH2 dtc).
13C NMR: 12.2 (CH3 dtc), 22.8 (CH3 acetate), 48.7 (CH2), 169.8 (COO), 196.6 (NCS2); IR (vmax
cm–1): 2950, 1660, 1497, 1075, 320; Analysis (%): for C12H23N2OS5Sb, found: Sb 23.54, S
32.11, C 28.93, H 4.58, N 5.49, calcd.: Sb 24.68, S 32.49, C 29.21, H 4.70, N 5.68.
(7) Brown solid; yield: 94 %, m.p.: 88oC, M.W. found (calcd.): 509 (517) g/mol; 1H NMR: δ
1.34 (t, J = 7.0 Hz, 24H, CH3 dtc), 2.05 (s, 3H, CH3 enolic), 2.22 (s, 3H, CH3 ketonic), 2.34 (s,
1H, CH acac), 3.80 (q, J = 7.0 Hz, 16H, CH2 dtc). 13C NMR: 12.2 (CH3 dtc), 24.8 (CH3 enolic),
30.9 (CH3 ketonic), 48.9 (CH2 dtc), 101.5 (CH enolic), 192.4 (C enolic), 196.1 (NCS2). IR (vmax
cm–1): 2910, 1700, 1510, 1070, 570, 310; Analysis (%): for C15H27N2O2S4Sb, found: Sb 23.41, S
24.65, C 34.63, H 5.01, N 5.29, calcd.: Sb 23.58, S 24.79, C 34.82, H 5.26, N 5.41.
(8) Yellow semi–solid; yield: 81%, M.W. found (calcd.): 518 (527) g/mol; 1H NMR: δ 1.23 (t, J
= 7.0 Hz, 24H, CH3 dtc), 3.62 (q, J = 7.0 Hz, 2H, CH2 dtc), 7.41 (m, 16H, C6H5). 13C NMR: 12.2
(CH3), 48.8 (CH2), 126.7 {C6H5(C–4)}, 128.5 {C6H4 (C–2, 3, 5 and 6)}, 129.5 {C6H4 (C–1)},
196.6 (NCS2); IR (vmax cm–1): 2985, 1505, 1055, 315; Analysis (%): for C16H25N2S5Sb, found:
Sb 22.83, S 30.24, C 36.32, H 4.60, N 5.26, calcd.: Sb 23.08, S 30.40, C 36.43, H 4.78, N 5.31.
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 14
(9) Yellow solid; yield: 90 %; m.p.: 72oC, M.W. found (calcd.): 920 (929) g/mol; 1H NMR: δ
1.25 (t, J = 7.5 Hz, 24H, CH3 dtc), 3.55 (s, 2H, SCH2 dithiol), 3.74 (q, J = 7.5 Hz, 16H, CH2 dtc).
13C NMR: 12.4 (CH3), 42.3 (SCH2 dithiol), 49.0 (CH2 dtc), 196.5 (NCS2); IR (vmax cm–1): 2990,
1495, 1070, 305; Analysis (%): for C22H44N4S10Sb2, found: Sb 25.90, S 33.98, C 28.28, H 4.65,
N 5.99, calcd.: Sb 26.22, S 34.52, C 28.45, H 4.78, N 6.03.
(10) Light yellow solid; yield: 85 %, m.p.: 83oC, M.W. found (calcd.): 933 (939) g/mol; 1H
NMR: δ 0.82 (s, 6H, CH3 ligand), 1.26 (t, J = 7.0 Hz, 24H, CH3 dtc), 3.41 (s, 2H, OCH2), 3.74 (q,
J = 7.0 Hz, 16H, CH2 dtc). 13C NMR: 12.3 (CH3 dtc), 21.4 (CH3 ligand), 36.5 (C quaternary),
42.4 (OCH2), 49.0 (CH2 dtc), 196.5 (NCS2); IR (vmaxcm–1): 2990, 1490, 1060, 560, 310; Analysis
(%): for C25H50N4O2S8Sb2, found: Sb 25.81, S 27.15, C 31.87, H 5.31, N 5.89, calcd.: Sb
25.94, S 27.33, C 31.99, H 5.37, N 5.97.
CONCLUSION
The synthesis of bis(diethyldithiocarbamato)antimony(III) derivatives with oxygen and sulfur
donor ligands was accomplished and their structures characterized tentatively to be crystalline in
nature, rough surface, exist as agglomerates, nano range particle size (3.19 to 3.64 nm) and
having distorted octahedral geometry with monoclinic crystal system by elemental analysis,
spectral data (IR, 1H, 13C NMR, ESI–mass) SEM, and powder XRD.
Acknowledgements
Financial Assistance from University grant commission [F.39-801/2010(SR)], New Delhi is
gratefully acknowledged. We are also thankful to School of Studies in Chemistry, Vikram
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 15
University, Ujjain; SAIF, IIT Bombay and UGC–DAE–CSR, Indore for FT–IR, far–IR spectra,
and Powder XRD and SEM studies respectively.
References
[1]. Kenneth, W. W.; Houghton, C. L.; Sedlak, D. L. Anal. Chem. 1998, 70, 4800–4804.
[2]. Cvek, B.; Melacic, V.; Taraba, J.; Dou, Q. P. J. Med. Chem. 2008, 51, 6256–6258.
[3]. Kateva, J.; Ivanou, S. K.; J. Polym. Sci. Part A: Polym. Chem. 1979, 17, 2707–2718.
[4]. Plyusnin, V. F.; Kolomeets, A. V.; Grivin, V. P.; Larinov, S. V.; Lemmetyinen, H. J.
Phys. Chem. A. 2011, 115, 1763–1773.
[5]. Regulacio, M. D.; Tomson, N.; Stoll, S. L. Chem. Mater. 2005, 17, 3114–3121.
[6]. Jian, F.; Bei, F.; Zhao, P.; Wang, X.; Fun, H.; Chinnakali, K. J. Coord. Chem. 2002, 55,
429–437.
[7]. Sheng, T.; Wu, X.; Lin, P.; Zhang, W.; Wang, Q.; Chen, L. Polyhedron 1999, 18,
1049–1054.
[8]. Phillips, D. J.; Oscar, F. L. Additions for lubricants: Mobil oil. W01995/0199441. 1995
Jul 20.
[9]. Willingham G. L. Use of antimony salt stabilizers for 3–isothiazolones. US Patent
5,145,981. 1992 Sep 8.
[10]. Takahashi, S.; Sato, H.; Kubota, Y.; Utsumi, H.; Bedford, J. S.; Okayasu, R.
Toxicology. 2002, 180, 249–256.
[11]. Cantos, G.; Barbieri, C. L.; Iacomini, M.; Gorin, P. A. J.; Travassos, L. R. Biochem. J.
1993, 289, 155–160.
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 16
[12]. Khan, M. I.; Gul, S.; Hussain, I.; Khan, M. A.; Ashfaq, M.; Rahman, I. U.; Ullah, F.;
Durrani, G. F.; Baloch, I. B.; Naz, R. Org. Med. Chem. Lett. 2011, 1, 1–7.
[13]. Ozturk, I. I.; Kourkoumelis, N.; Hadjikakou, S. K.; Manos, M. J.; Tasiopoulos, A. J.;
Bulter, I. S.; Balzarini, J.; Hadjiliadis, N. J. Coord, Chem. 2011, 64, 3859–3871.
[14]. Silvestru, C.; Curtui, M.; Haiduc, I.; Begley, M. J.; Sowerby, D. B. J. Organomet.
Chem. 1992, 426, 49–58.
[15]. Agrawal, R.; Sharma, J.; Singh, Y.; Nandani, D.; Batra, A. Phosphorus Sulfur Silicon
Relat. Elem. 2010, 185, 516–525.
[16]. Silvestru, C.; Socaciu, C.; Bara, A.; Haiduc, I. Anticancer Res. 1990, 10, 803–804.
[17]. Oliveira, L. G.; Silva, M. M.; Paula, F. C. S.; Pereira, E. C.; Donnici, C. L.; Simone, C.
A. Molecules 2011, 16, 0314–0323.
[18]. Ranconi, L.; Giovagnini, L.; Marzano, C.; Bettio, F.; Graziani, R. Inorg. Chem. 2005,
44, 1867–1881.
[19]. Sharma, P. K.; Rehwani, H.; Rai, A. K.; Gupta, R. S.; Singh, Y. P. Bioinorg. Chem.
Appl. 2006 DOI: 10.1155/BCA/2006/16895
[20]. Chauhan, H. P. S.; Bhatiya, S.; Bakshi, A.; Makwana, K. S. Phosphorus Sulfur Silicon
Relat. Elem. 2011, 186, 511–519.
[21]. Chauhan, H. P. S.; Bakshi, A.; Bhatiya, S. Phosphorus Sulfur Silicon Relat. Elem.
2011, 186, 345–353.
[22]. Chauhan, H. P. S.; Bakshi, A.; Bhatiya, S. Appl. Organomet. Chem. 2010, 24, 317–325.
[23]. Chauhan, H. P. S.; Bhatiya, S.; Bakshi, A. Spectrochim. Acta Part A. 2009, 74, 67–73.
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 17
[24]. Hussain, A.; Nami, S. A. A.; Singh, S. P.; Oves, M.; Siddiki, K. S. Polyhedron 2011,
30, 33–40.
[25]. Bonati, F.; Ugo, R. J. Organomet. Chem. 1967, 10, 257–268.
[26]. Chauhan, H. P. S.; Bhatiya, S.; Bakshi, A. Appl. Organomet. Chem. 2010, 24, 317–325.
[27]. Geraldo, M. L.; Daniele, C. M.; Jacqueline, A. F. S.; James, L. W.; Carlos, A. L. F.;
Antonio, F. C. A.; Solange, M. S. V.; Nevaldo, L. S. J. Coord. Chem. 2012, 65, 559–
571.
[28]. Kheiric, F. M. N.; Tsipis, C. A.; Tsiamis, C. L.; Manoussakis, G. A. Can. J. Chem.
1979, 57, 767–772.
[29]. Riekolla, M. L. Acta Chemica Candinavika A. 1983, 37, 91–101.
[30]. Cullity, B. D. Elements of X–ray diffraction. USA; Addison–Wesley Publishing
Company; 1958.
[31]. Riddick, J. A.; Bunger, W. B. Techniques of chemistry (organic solvents). 3rd ed. New
York: Wiley Inter Science; 1970.
[32]. Vogel, A. I. A textbook of quantitative chemical analysis. 6th ed. India: Saurabh
Printers; 2008.
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 18
10 20 30 40 50
0
1000
2000
3000
4000
5000
Inte
nsitie
s (
cp
s)
2 theta
Figure 1: Powder XRD pattern of bis(diethyldithiocarbamato)antimony(III) benzoate 4
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 19
Figure 2: Proposed structure of bis(diethyldithiocarbamato)antimony(III) thiophenolate 8
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 20
Figure 3: Proposed structure of di-µ-ethane-1,2-dithiolato
bis(diethyldithiocarbamato)antimony(III) 9
Scheme 1: Synthesis of bis(diethyldithiocarbamato)antimony(III) acetate.
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 21
Scheme 2: Synthesis of di-µ-oxolatobis(diethyldithiocarbamato)antimony(III).
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT 22
Dow
nloa
ded
by [
Uni
vers
ity o
f H
aifa
Lib
rary
] at
22:
12 2
6 A
ugus
t 201
3